Medical Xpress news

Medical Xpress / Obese patients undergoing shoulder replacement surgery face no increased safety risk, study finds

Higher BMI is not linked to increased risk of death or other complications following shoulder replacement surgery, according to a study by Epaminondas Markos Valsamis from the University of Oxford, UK, and colleagues published ...

Nov 20, 2025 in Surgery
Medical Xpress / AI-assisted interviews can increase accuracy in diagnosing mental illness

A new study shows that an AI assistant can conduct assessment conversations with patients with higher accuracy than the rating scales used in health care today. In the study, 303 participants were interviewed by the AI assistant ...

Nov 20, 2025 in Psychology & Psychiatry
Medical Xpress / Chronic hepatitis C linked to increased risk of pancreatic cancer

A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic cancer. The study, which was published in JAMA Network Open, revealed that individuals with chronic ...

Nov 20, 2025 in Oncology & Cancer
Medical Xpress / New therapeutic strategies show promise against a hard-to-treat prostate cancer

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

Nov 20, 2025 in Oncology & Cancer
Medical Xpress / French scientists probe mRNA's potential to fight cancer

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger RNA—best known for being used in COVID-19 vaccines—in the hopes of finding a breakthrough treatment ...

Nov 20, 2025 in Medical research
Medical Xpress / Study suggests type 1 diabetes may significantly raise bladder cancer risk

People with type 1 diabetes (previously called juvenile diabetes) are 4.29 times more likely to develop bladder cancer, according to a systematic review and meta-analysis by researchers at the Keck School of Medicine of USC. ...

Nov 20, 2025 in Oncology & Cancer
Medical Xpress / New cholesterol-lowering pill reduces bad cholesterol levels by almost 60%

Trials of a new cholesterol-lowering pill have shown promising results for people with heterozygous familial hypercholesterolemia (HeFH), a genetic disorder that leads to high levels of LDL cholesterol.

Nov 19, 2025 in Medications
Medical Xpress / Taking prenatal supplements associated with 30% lower risk of autism

Researchers from Curtin University in Australia and multiple universities in Ethiopia report that prenatal folic acid and multivitamin supplementation is associated with a roughly 30% lower risk of autism spectrum disorder ...

Nov 19, 2025 in Autism spectrum disorders
Medical Xpress / Microglia modulate the reactivity of astrocytes in Alzheimer's disease, study finds

Alzheimer's disease (AD) is a highly debilitating neurodegenerative disease characterized by the progressive loss of memory and decline of mental functions. Earlier research has uncovered some of the neural and biological ...

Medical Xpress / Zalunfiban shows early benefits in ST-elevation heart attacks

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug zalunfiban given at first medical contact for suspected ST-elevation myocardial infarction (STEMI) improved ...

Nov 19, 2025 in Medications
Medical Xpress / Cancer uses cell death proteins to survive treatment and regrow

The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need to devise approaches to mitigate it. However, the molecular mechanisms driving treatment resistance ...

Nov 19, 2025 in Oncology & Cancer
Medical Xpress / Turning tumor's shield into a sword: Scientists target macrophages to overcome immunotherapy resistance

Immunotherapy, which harnesses our body's own immune system to fight cancer, has revolutionized modern oncology. Yet despite its success with several cancers, many patients still fail to respond to therapy or experience relapse ...

Nov 19, 2025 in Oncology & Cancer